Cite
HARVARD Citation
Kaufman, H. et al. (n.d.). Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2. Journal for immunotherapy of cancer. p. . [Online].